HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rebecca Dent Selected Research

Rebecca Dent Research Topics

Disease

38Breast Neoplasms (Breast Cancer)
10/2023 - 11/2005
27Triple Negative Breast Neoplasms
01/2024 - 08/2007
20Neoplasms (Cancer)
11/2023 - 05/2009
5Pathologic Complete Response
11/2023 - 01/2010
4Neutropenia
05/2022 - 07/2012
3Disease Progression
09/2021 - 10/2017
2Nausea
12/2023 - 07/2012
2Fatigue
12/2023 - 04/2018
2Neoplasm Metastasis (Metastasis)
10/2021 - 06/2019
2Arthralgia (Joint Pain)
01/2018 - 01/2016
2Cognitive Dysfunction
01/2018 - 02/2016
2Pain (Aches)
01/2018 - 01/2016
2Myalgia
01/2018 - 01/2016
1Alopecia (Baldness)
12/2023
1Vomiting
12/2023
1Carcinoma in Situ
11/2023
1Genetic Risk Score
05/2022
1Fever (Fevers)
05/2022
1Febrile Neutropenia
05/2022
1Brain Neoplasms (Brain Tumor)
01/2022
1Pancytopenia
01/2021
1Shock
01/2021
1Sepsis (Septicemia)
01/2021
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2019
1Sleep Initiation and Maintenance Disorders (Insomnia)
04/2018
1Mitochondrial Diseases (Mitochondrial Disease)
04/2018
1Chemotherapy-Related Cognitive Impairment
04/2018
1Glioma (Gliomas)
01/2018
1Acute Pain
01/2018
1Colitis
10/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

7pembrolizumabIBA
12/2023 - 01/2020
7Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 01/2016
6taxaneIBA
12/2023 - 11/2012
6Progesterone Receptors (Progesterone Receptor)IBA
01/2016 - 08/2007
6Estrogen ReceptorsIBA
01/2016 - 08/2007
5PlatinumIBA
01/2024 - 08/2014
5Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2010
5human ERBB2 proteinIBA
10/2023 - 11/2009
4ipatasertibIBA
12/2023 - 10/2017
3130-nm albumin-bound paclitaxelIBA
12/2023 - 01/2016
3Hormones (Hormone)IBA
06/2023 - 01/2017
3ErbB Receptors (EGF Receptor)IBA
06/2023 - 11/2009
3Epirubicin (Ellence)FDA LinkGeneric
10/2022 - 01/2010
3Trastuzumab (Herceptin)FDA Link
01/2022 - 11/2005
3AnthracyclinesIBA
01/2021 - 11/2012
3Docetaxel (Taxotere)FDA Link
01/2018 - 01/2010
2Immune Checkpoint InhibitorsIBA
12/2023 - 06/2019
2atezolizumabIBA
12/2023 - 06/2019
2LigandsIBA
11/2023 - 01/2019
2Carboplatin (JM8)FDA LinkGeneric
10/2022 - 01/2020
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 01/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 01/2020
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019 - 10/2010
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2018
2TamoxifenFDA LinkGeneric
10/2016 - 01/2016
2Bevacizumab (Avastin)FDA Link
09/2013 - 01/2011
1durvalumabIBA
01/2024
1olaparibIBA
01/2024
1trastuzumab deruxtecanIBA
10/2023
1Immunoconjugates (Immunoconjugate)IBA
10/2023
1Cyclin DIBA
06/2023
1Phosphotransferases (Kinase)IBA
06/2023
1Capecitabine (Xeloda)FDA Link
01/2022
1tucatinibIBA
01/2022
1RetinoidsIBA
10/2021
1Fatty Acids (Saturated Fatty Acids)IBA
10/2021
1Aromatase InhibitorsIBA
08/2021
1Cyclin-Dependent Kinase 4IBA
08/2021
1Genetic Markers (Genetic Marker)IBA
01/2021
1Circulating Tumor DNAIBA
11/2020
1B7-H1 AntigenIBA
09/2020
1Monoclonal AntibodiesIBA
09/2020
1ElementsIBA
01/2020
1poly ADP-ribose glycohydrolaseIBA
01/2019
1DNA-Activated Protein KinaseIBA
01/2019
1CytokinesIBA
04/2018
1Mitochondrial DNA (mtDNA)IBA
04/2018
1ProgesteroneFDA LinkGeneric
01/2018
1Temozolomide (Temodar)FDA LinkGeneric
01/2018
1Estrogens (Estrogen)FDA Link
01/2018
1O(6)-benzylguanineIBA
01/2018
1Phenobarbital (Luminal)FDA Link
01/2017
1Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2016
1methionylmethionine (Met-Met)IBA
02/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2016
1Cytochrome P-450 CYP2C19IBA
01/2016
1N,N-didesmethyl-4-hydroxytamoxifenIBA
01/2016
1Albumin-Bound PaclitaxelFDA Link
01/2016

Therapy/Procedure

22Drug Therapy (Chemotherapy)
01/2024 - 01/2010
20Therapeutics
01/2024 - 10/2010
10Neoadjuvant Therapy
11/2023 - 01/2010
4Mastectomy (Mammectomy)
11/2015 - 10/2007
3Immunotherapy
09/2020 - 09/2015
1Cryotherapy (Therapy, Cold)
01/2020
1Palliative Care (Palliative Therapy)
01/2019
1Aftercare (After-Treatment)
01/2018
1Radiotherapy
11/2015
1Adjuvant Radiotherapy
11/2015